Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $646.01 | 39 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $126.54 | 8 | $0 (2020) |
| Medtronic, Inc. | $109.49 | 3 | $0 (2024) |
| Allergan Inc. | $95.04 | 6 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $55.02 | 4 | $0 (2019) |
| PFIZER INC. | $52.95 | 4 | $0 (2021) |
| Nestle HealthCare Nutrition Inc. | $39.64 | 3 | $0 (2021) |
| IRONWOOD PHARMACEUTICALS, INC | $39.24 | 3 | $0 (2020) |
| Edwards Lifesciences Corporation | $27.37 | 1 | $0 (2022) |
| Takeda Pharmaceuticals America, Inc. | $21.48 | 1 | $0 (2017) |
| UCB, Inc. | $14.32 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.96 | 1 | Medtronic, Inc. ($24.96) |
| 2023 | $21.03 | 1 | Medtronic, Inc. ($21.03) |
| 2022 | $27.37 | 1 | Edwards Lifesciences Corporation ($27.37) |
| 2021 | $126.47 | 6 | Medtronic, Inc. ($63.50) |
| 2020 | $67.00 | 5 | IRONWOOD PHARMACEUTICALS, INC ($39.24) |
| 2019 | $161.55 | 11 | AbbVie, Inc. ($60.82) |
| 2018 | $45.29 | 3 | AbbVie, Inc. ($20.03) |
| 2017 | $172.34 | 11 | Allergan Inc. ($80.85) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/10/2024 | Medtronic, Inc. | NEXPOWDER (Device) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Therapeutic Endoscopy | ||||||
| 02/01/2023 | Medtronic, Inc. | ELEVIEW (Device) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Therapeutic Endoscopy | ||||||
| 08/03/2022 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: Transcatheter Heart Valves | ||||||
| 12/15/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/04/2021 | Medtronic, Inc. | EndoFlip (Device) | Food and Beverage | In-kind items and services | $63.50 | General |
| Category: Motility Testing | ||||||
| 09/15/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/14/2021 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $11.98 | General |
| 06/23/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 03/03/2021 | Cook Medical LLC | Hemospray (Device) | Food and Beverage | Cash or cash equivalent | $11.35 | General |
| Category: Endoscopy | ||||||
| 10/13/2020 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), GIVLAARI | Food and Beverage | Cash or cash equivalent | $13.08 | General |
| Category: GI | ||||||
| 03/02/2020 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), GIVLAARI | Food and Beverage | Cash or cash equivalent | $13.08 | General |
| Category: GI | ||||||
| 02/12/2020 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/30/2020 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), GIVLAARI | Food and Beverage | Cash or cash equivalent | $13.08 | General |
| Category: GI | ||||||
| 01/13/2020 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 11/21/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Endocrinology | ||||||
| 11/05/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Endocrinology | ||||||
| 10/01/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/12/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/10/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/19/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Endocrinology | ||||||
| 03/12/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/01/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 02/28/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $16.06 | General |
| 02/06/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 637 | 684 | $225,049 | $69,582 |
| 2022 | 16 | 751 | 807 | $301,096 | $92,826 |
| 2021 | 14 | 786 | 934 | $333,466 | $101,076 |
| 2020 | 15 | 779 | 898 | $303,154 | $94,248 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 79 | 79 | $58,875 | $14,170 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 138 | $20,424 | $12,900 | 63.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 70 | 70 | $44,850 | $8,150 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 93 | 115 | $11,500 | $7,108 | 61.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 76 | 76 | $28,750 | $6,125 | 21.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $11,400 | $6,095 | 53.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 26 | 26 | $14,918 | $4,576 | 30.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $10,530 | $2,279 | 21.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 21 | $5,880 | $2,257 | 38.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 26 | 26 | $8,610 | $1,916 | 22.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 20 | $2,880 | $1,884 | 65.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $3,725 | $1,538 | 41.3% |
| 43450 | Dilation of esophagus | Facility | 2023 | 19 | 19 | $2,708 | $583.96 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 142 | 163 | $24,124 | $15,559 | 64.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 76 | 76 | $57,000 | $14,538 | 25.5% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2022 | 18 | 18 | $54,000 | $10,973 | 20.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 129 | 151 | $15,100 | $9,985 | 66.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $10,944 | $5,934 | 54.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 52 | 52 | $33,800 | $5,769 | 17.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 69 | 69 | $33,750 | $5,608 | 16.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 31 | $8,680 | $4,860 | 56.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 31 | 44 | $6,336 | $3,643 | 57.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 19 | 19 | $11,115 | $3,612 | 32.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 26 | 26 | $15,210 | $3,237 | 21.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 33 | 33 | $4,917 | $2,940 | 59.8% |
About Dr. Payam Chini, MD
Dr. Payam Chini, MD is a Gastroenterology healthcare provider based in Gainesville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063501039.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Payam Chini, MD has received a total of $646.01 in payments from pharmaceutical and medical device companies, with $24.96 received in 2024. These payments were reported across 39 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($646.01).
As a Medicare-enrolled provider, Chini has provided services to 2,953 Medicare beneficiaries, totaling 3,323 services with total Medicare billing of $357,731. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Gainesville, FL
- Active Since 10/11/2006
- Last Updated 09/03/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063501039
Products in Payments
- VIBERZI (Drug) $80.85
- EndoFlip (Device) $63.50
- Creon (Drug) $60.07
- DIFICID (Drug) $43.43
- XELJANZ (Drug) $40.97
- ZENPEP (Drug) $39.64
- Linzess (Drug) $39.24
- Mavyret (Drug) $35.29
- ELEVIEW (Device) $34.90
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $27.37
- NEXPOWDER (Device) $24.96
- Dexilant (Drug) $21.48
- CREON (Drug) $15.12
- Cimzia (Drug) $14.32
- LINZESS (Drug) $14.19
- Movantik (Drug) $13.53
- XIFAXAN (Drug) $13.53
- OCALIVA (Drug) $12.64
- ZEPATIER (Drug) $11.59
- Hemospray (Device) $11.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Gainesville
Charles Sninsky, Md, MD
Gastroenterology — Payments: $1.2M
Peter Draganov, Md, MD
Gastroenterology — Payments: $1.1M
Christopher Forsmark, Md, MD
Gastroenterology — Payments: $94,323
Ahmed Ouni
Gastroenterology — Payments: $31,897
Virginia Clark, Md, MD
Gastroenterology — Payments: $23,687
Dr. Roniel Cabrera, Md, MD
Gastroenterology — Payments: $22,274